In the previous analysis, we found that NOS2 was significantly down-regulated in the high-risk group, and in the left-sided and right-sided colon cancer, patients with T3-4 and stage III-IV had relatively high risk score levels. This evidence concerns the gene NOS2 and colonic neoplasm.